Abstract

Sjögren's syndrome (SjS) is characterized by lymphocytic infiltration of exocrine glands, i.e. autoimmune epithelitis. Lymphocytes are central in SjS pathogenesis, with B-cell hyperactivity mediated by T-cells. B-cells are main targets of Epstein-Barr virus (EBV) infection, a frequently-suggested trigger for SjS. We aimed to evaluate how the EBV infection modulates B and T-cell subsets in SjS, including as controls Rheumatoid arthritis patients (RA) and healthy participants (HC). SjS patients presented decreased CXCR5+T-cells, although IL21-secreting Tfh and Tfc cells were increased. Tfc were positively correlated with ESSDAI scores, suggesting their relevant role in SjS pathogenesis. As previously described, SjS patients showed expanded circulating naïve B-cell compartments. SjS patients had a higher incidence of EBV-EA-D-IgG+ antibodies, characteristic of recent EBV-infection/reactivation. SjS patients with past infection or recent infection/reactivation showed increased CXCR3+Th1 and CXCR3+Tfh1 cells compared to those without active infection. SjS patients with a recent infection/reactivation profile presented increased transitional B-cells compared to patients with past infection and increased plasmablasts, compared to those without infection. Our results suggest EBV-infection contributes to B and T-cell differentiation towards the effector phenotypes typical of SjS. Local lymphocyte activation at ectopic germinal centres, mediated by Tfh and Tfc, can be EBV-driven, perpetuating autoimmune epithelitis, which leads to gland destruction in SjS.

Highlights

  • Sjögren’s syndrome (SjS) is a chronic systemic autoimmune disease, with an estimated prevalence between 0.2–0.5%1, affecting predominantly middle-aged women

  • The percentages of IL21-secreting ­CD4+ T-cells were increased in SjS patients when compared to both Rheumatoid Arthritis (RA) patients and healthy participants (HC) (p < 0.0001)

  • Our study aimed to explore the relation between the Epstein-Barr virus (EBV) serological profile of SjS patients and the distribution of circulating B and T-lymphocyte subsets

Read more

Summary

Introduction

Sjögren’s syndrome (SjS) is a chronic systemic autoimmune disease, with an estimated prevalence between 0.2–0.5%1, affecting predominantly middle-aged women. It is characterized by lymphocytic infiltration of the exocrine glands, referred to as autoimmune ­epithelitis[2]. In SjS, T-cells infiltrate affected organs, like the SG, and support hyperactivity of B-cells[8]. Follicular helper T-cells (Tfh) have been addressed as players in SjS pathogenesis. Helper T-cells sustain cytotoxic T-cell responses as long as viral antigens ­persist[18]. The proinflammatory Th1 profile, usually present in acute viral infections, is somehow replaced by Tfh in response to viral persistence and prolonged T-cell receptor ­stimulation[19]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call